Desmoglein-2 is important for islet function and β-cell survival

Kay K Myo Min, Darling Rojas-Canales, Daniella Penko, Mark DeNichilo, Michaelia P Cockshell, Charlie B Ffrench, Emma J Thompson, Olof Asplund, Christopher J Drogemuller, Rashmi B Prasad, Leif Groop, Shane T Grey, Helen E Thomas, Thomas Loudovaris, Thomas W Kay, My G Mahoney, Claire F Jessup, P Toby Coates, Claudine S Bonder

Research output: Contribution to journalArticlepeer-review


Type 1 diabetes is a complex disease characterized by the lack of endogenous insulin secreted from the pancreatic β-cells. Although β-cell targeted autoimmune processes and β-cell dysfunction are known to occur in type 1 diabetes, a complete understanding of the cell-to-cell interactions that support pancreatic function is still lacking. To characterize the pancreatic endocrine compartment, we studied pancreata from healthy adult donors and investigated a single cell surface adhesion molecule, desmoglein-2 (DSG2). Genetically-modified mice lacking Dsg2 were examined for islet cell mass, insulin production, responses to glucose, susceptibility to a streptozotocin-induced mouse model of hyperglycaemia, and ability to cure diabetes in a syngeneic transplantation model. Herein, we have identified DSG2 as a previously unrecognized adhesion molecule that supports β-cells. Furthermore, we reveal that DSG2 is within the top 10 percent of all genes expressed by human pancreatic islets and is expressed by the insulin-producing β-cells but not the somatostatin-producing δ-cells. In a Dsg2 loss-of-function mice (Dsg2lo/lo), we observed a significant reduction in the number of pancreatic islets and islet size, and consequently, there was less total insulin content per islet cluster. Dsg2lo/lo mice also exhibited a reduction in blood vessel barrier integrity, an increased incidence of streptozotocin-induced diabetes, and islets isolated from Dsg2lo/lo mice were more susceptible to cytokine-induced β-cell apoptosis. Following transplantation into diabetic mice, islets isolated from Dsg2lo/lo mice were less effective than their wildtype counterparts at curing diabetes. In vitro assays using the Beta-TC-6 murine β-cell line suggest that DSG2 supports the actin cytoskeleton as well as the release of cytokines and chemokines. Taken together, our study suggests that DSG2 is an under-appreciated regulator of β-cell function in pancreatic islets and that a better understanding of this adhesion molecule may provide new opportunities to combat type 1 diabetes.

Original languageEnglish
Article number911
JournalCell Death & Disease
Issue number10
Publication statusPublished - 2022 Oct 29

Bibliographical note

© 2022. The Author(s).

Subject classification (UKÄ)

  • Cell and Molecular Biology

Free keywords

  • Mice
  • Humans
  • Animals
  • Diabetes Mellitus, Type 1/metabolism
  • Diabetes Mellitus, Experimental/genetics
  • Streptozocin
  • Cell Survival
  • Islets of Langerhans/metabolism
  • Insulin/metabolism
  • Desmogleins/metabolism


Dive into the research topics of 'Desmoglein-2 is important for islet function and β-cell survival'. Together they form a unique fingerprint.

Cite this